Gene Editing Market Trends

Gene Editing Market Trends

Rising funding for genetic study in developed regions including North America will drive the gene editing market growth over the forecast period. In the U.S., more than 20 federal agencies funded research and development government firms to produce useful materials, devices, and methods. Moreover, the U.S. government funds various research firms that help in the development and manufacturing of drug discovery for various rare genetic diseases. For instance, the National Human Genome Research Institute supports research programs and project to advance in the field of genomics.
 

Similarly, The National Institutes of Health (NIH), a part of the U.S. government’s Health and Human Services and nation’s medical research agency is responsible for research activities in genetics and biomedical. Recently in 2021, NIH funded around USD 1.6 million to the Arizona State University and Bayer College of Medicine for evaluating recent advancements in human genome editing. Recently developed drugs specifically for the treatment of genetic disorders have decreased the mortality rate that will boost the gene editing market growth in the expected future.